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It is now well documented that lecithin-retinol acyltransferase (LRAT) is the physiologically important enzyme activity involved in the esterification 
of retinol in the liver. However, no information regarding the cellular distribution of this enzyme in the liver is presently available. This study 
characterizes the distribution of LRAT activity in the different types of rat liver cells. Purified preparations of isolated parenchymal, fat-storing, 
and Kupffer + endothelial cells were isolated from rat livers and the LRAT activity present inmicrosomes prepared from each of these cell fractions 
was determined. The fat-storing cells were found to contain the highest level of LRAT specific activity (383 + 54 pmol retinyl ester formed 
min-l'mg-~ versus 163 + 22 pmol retinyl ester formed min-~'mg -~ for whole liver microsomes). The level of LRAT specific activity in parenchymal 
cell microsomes (158 + 53 pmol retinyl ester formed min-l'mg -~) was very similar to LRAT levels in whole liver microsomes. The Kupffer + en- 
dothelial cell microsome fractions were found to contain LRAT, at low levels of activity. These results indicate that the fat-storing cells are very 
enriched in LRAT but the parenchymal cells also possess ignificant levels of LRAT activity. 
Fat-storing cell; Hepatic parenchymal cell; Retinoid; Cellular etinol-binding protein; Retinol esterification; LRAT 
1. INTRODUCTION 
The liver is the site of storage of the majority of the 
body's retinoid (vitamin A) reserves [1]. Within the 
liver, more than 800  of this retinoid is stored as retinyl 
ester in fat-storing cells (also called lipocytes, Ito cells 
and stellate ceils) [2-5]. This small and relatively 
unabundant non-parenchymal cell, which accounts for 
about 1°7o of hepatic protein and less than lOe/o of the 
total cells present in the liver, is dynamically involved in 
hepatic retinoid storage and metabolism (see [6] for re- 
cent review). Fat-storing cells have been shown to be 
greatly enriched in the important retinoid-related 
parameters of cellular retinol-binding protein (CRBP), 
cellular retinoic acid-binding protein (CRABP), and 
retinyl ester hydrolase (REH), in addition to containing 
very high levels of retinyl esters [3,4]. 
The parenchymal cells are also very important in 
hepatic retinoid metabolism. These ceils, which take up 
dietary retinoid in the form of retinyl esters in 
chylomicron remnants [7], contain relatively low levels 
of retinyl esters but substantial levels of CRBP and 
REH [3,4] and are the hepatic site for the synthesis of 
the serum transport protein for retinol, retinol-binding 
protein (RBP) [8]. Although much information regar- 
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ding hepatic retinoid metabolism has become available 
in recent years, many questions regarding this topic re- 
main to be answered. Amongst hese, is the question of 
the metabolic origin of the retinyl esters found in the 
parenchymal nd fat-storing cells. 
Since the first description of the enzyme catalyzed 
acyl CoA-independent synthesis of retinyl ester by Ong 
et al. [9] in 1987, evidence has accumulated that an acyl 
CoA-independent enzymatic activity is the physiolog- 
ically important process involved in retinol esterifica- 
tion [9-16]. This enzymatic activity has been shown to 
utilize phosphatidyl choline as the acyl donor for retinol 
esterification and has been termed lecithin-retinol 
acyltransferase (LRAT) by MacDonald and Ong [11]. 
At present he LRAT activity has been shown to be the 
physiologically important activity for retinol esterifica- 
tion in rat small intestine [9], rat liver [11-13], human 
liver [11], bovine eye [10,14], and rat testis [15,16]. 
The studies described in this manuscript aim to ex- 
plore the distribution of hepatic LRAT activity in the 
different types of liver cells. We now report informa- 
tion concerning the question of whether the large quan- 
tities of retinyl ester present in fat-storing cells can arise 
from the actions of LRAT activity present in these cells. 
We also explore the question of whether the relatively 
low levels of retinyl esters present in parenchymal cells 
arise solely from the uptake of chylomicron remnant 
retinyl ester or, alternatively, through the enzymatic 
esterification of retinol within the parenchymal cells. 
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2. MATERIALS AND METHODS 
Hepatic cells were isolated from 12 month-old female BN/BiRij 
rats. For parenchymal cell isolations, the liver was digested with col- 
lagenase and the parenchymal cells were purified by centrifugal 
elutriation as described previously [2,3]. The parenchymal cell 
preparations were greater than 99%o pure as judged by light 
microscopy. Hepatic fat-storing cells were isolated using the pronase 
E digestion-Nycodenz centrifugation procedure described by Hen- 
driks et al. [2]. Each of the fat-storing cell preparations u ed in this 
study was greater than 80% pure as judged by light microscopy and 
contained to detectable parenchymal cell contamination (the remain- 
ing cells present in these preparations were primarily hepatic Kupffer 
and endothelial cells). The preparations of Kupffer + endothelial 
cells were prepared as described by Hendriks et al. [2] and contained 
approximately 10-15% contamination with fat-storing cells. 
Microsomes were obtained from whole livers of 12 month-old 
BN/BiRij rats according to the procedure described by Ong et al. [12]. 
The microsomal pellet derived from this procedure was resuspended, 
using a Dounce homogenizer, in 0.2 M potassium phosphate, pH 7.2, 
containing 1mM DTT to a final microsomal protein concentration f 
l0 mg/ml. Microsomes were prepared from purified parenchymal, 
fat-storing, and Kupffer + endothelial cells by first resuspending a 
cell pellet in 5 ml (for the parenchymal cells) or 2 ml (for fat-storing 
and Kupffer + endothelial cells) of 0.2 M potassium phosphate, pH 
7.2, containing 1 mM DTT followed by homogenizing with 20 strokes 
of a tight-fitting Dounce homogenizer. Microsomes were isolated 
from these cell homogenates u ing exactly the same procedures 
employed for the whole liver homogenates [12]. All microsomal 
preparations were either used for LRAT assay or were frozen in 100 
p.l aliquots at -70°C prior to assay. LRAT activity remained stable 
for at least 1 month under these storage conditions. 
Fat-storing cell lipid droplets were isolated from purified fat- 
storing cells as described by Yamada et al. [8]. 
The standard LRAT assay incubation mixture consisted of 10 #M 
retinol bound to purified CRBP at 30/~g microsomal protein in an 
assay buffer consisting of 0.2 M potassium phosphate, pH 7.2, and 1 
mM DTT. The final assay volume was 0.2 ml and all incubations were 
carried out for 5 min at 37°C in a darkened room. All LRAT assays 
were carried out under appropriate conditions (time, temperature, 
substrate concentrations, and protein concentration) to ensure that 
linear enzyme reaction rates were measured. This assay procedure is
identical to the LRAT assay described by Ong et al. [12] except for the 
retinol-CRBP concentration (10 #M in our study as opposed to 5 ~M 
as used by Ong et al. [12]). Our basis for choosing this higher 
retinol-CRBP concentration is given below in sections 3 and 4. The 
retinyl esters produced in the assay were extracted into hexane and 
separated from the substrate retinol, either by chromatography on 
alumina [10] or by reverse phase H PLC [ 17]. These alternative s para- 
tion procedures gave identical measures of LRAT activity. 
3. RESULTS 
Our initial experiments were designed to set up and 
characterize the assay for LRAT in whole rat liver 
microsome. The assay we employed was originally 
described by Ong et al. [12] and later by Yost et al. [13]. 
It was our intent, before characterizing the distribution 
of LRAT in different kinds of isolated liver cells, to 
verify that we were indeed observing the same LRAT 
activity in rat liver microsomes that has been reported 
by these investigators [12,13]. Like these authors, we 
found that retinol bound to CRBP was the preferred 
substrate for LRAT in liver microsomes. The rate of 
retinyl ester formation was approximately 5-fold larger 
when 20 #M retinol was added as a retinol-CRBP com- 
plex to the assay mixture containing the liver micro- 
somes, as opposed to adding (at the same concentra- 
tion) either retinol bound to ~-lactoglobulin (a protein 
which binds retinol and may be important for the in- 
testinal uptake of dietary retinol [18]) or retinol solubil- 
ized in a small volume of ethanol. In our hands, the 
liver microsomal LRAT activity showed properties, 
with regards to microsomal protein-, pH, and time- 
dependence, similar to those reported by Ong et al. [12] 
and Yost et al. [13]. Our studies explored the depend- 
ence of the rate of retinyl ester formation on 
retinol-CRBP concentration over a wider range of 
substrate (retinol-CRBP) concentrations than either of 
these two earlier studies [12,13]. Fig. 1 shows the results 
from our studies where retinol-CRBP concentration 
was varied from 0.5 #M to 20 #M. From Fig. 1, Panel 
A, it can be seen, that at retinol-CRBP concentrations 
of 10 #M, the rate of reaction appears to be only star- 
ting to approach saturation and saturation seems nearly 
reached at 20 #M. Fig. 1, Panel B, shows a plot of the 
Lineweaver-Burk transformation of the data presented 
in Panel A. The calculated Km of the LRAT activity for 
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Fig. 1 Dependence of the rate of retinyl ester formation on 
retinol-CRBP concentration in the LRAT incubation mixture. Panel 
A shows the relationship between the rate of retinyl ester formation 
by 30/~g of liver microsomes and retinol-CRBP concentration. Panel 
B presents a Lineweaver-Burk plot of the data presented in Panel A. 
All assays were carried out under conditions which provided linear 
reaction rates for 5 min at 37°C. Each plotted value represents he 
average of at least 3 independent assays. 
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Table I 
Apparent LRAT activity levels in isolated liver cell microsomes and 
fat-storing cell lipid droplets 
Fractions (n) Activity a 
Whole liver microsomes 4 163 + 22 
Parenchymal cell microsomes 7 158 _+ 53 
Fat-storing cell microsomes 7 383 + 54 
Fat-storing cell lipid droplets 4 124 + 50 
Kupffer + endothelial cell microsomes 3 134 + 21 
aAll LRAT assays were carried out under appropriate conditions 
(time, temperature, substrate concentrations, and protein concentra- 
tion) to ensure that linear enzyme reaction rates were measured. 
LRAT activities are expressed as pmol of retinyl ester form- 
ed/min/mg protein and are given as mean +_ 1 SD 
retinol-CRBP is 2.2 #M and for this set of experiments 
a Vmax of 144 pmol retinyl ester formed min- ~ • mg- 1 
was obtained. These values are very similar to those 
reported by Ong et al. [12] and Yost et al. [13]. In addi- 
tion, as these authors [12,13] have reported for the 
LRAT activity present in whole liver microsomes, 
retinyl palmitate, retinyl stearate, and retinyl oleate ac- 
count for greater than 95% of the retinyl esters produc- 
ed by all of the cellular microsomal preparations ex- 
amined. 
The overall goal of our studies was to determine the 
levels of LRAT activity present in different types of rat 
liver cells. We have measured LRAT activity levels in 
whole rat liver, parenchymal cell, fat-storing cell, and 
Kupffer + endothelial cell microsomes and in isolated 
fat-storing cell lipid droplets. The LRAT activity levels 
for each of these preparations is given in Table I. The 
fat-storing cell microsomes were found to possess the 
highest specific activities of LRAT of any of the liver 
cell fractions examined. Whole liver microsomes and 
parenchymal cell microsomes displayed approximately 
the same levels of LRAT activity but these levels were 
only about 42% of the LRAT activity level measured in
fat-storing cell microsomes. By considering the 
estimated number of parenchymal cells, fat-storing 
cells, and Kupffer + endothelial cells present in one 
gram of liver and the recoveries of microsomal protein 
from known numbers of each cell preparation, it is 
possible to estimate the relative pools of hepatic LRAT 
present in each of these cell fractions. Such estimates in- 
dicate that approximately 85°70 of hepatic LRAT is pre- 
sent in parenchymal cells and approximately 10% in 
fat-storing cells. This distribution isquite similar to the 
cellular distribution of CRBP in the different cell types 
of the rat liver [3]. 
4. DISCUSSION 
LRAT has now been demonstrated by a number of 
laboratories tobe the physiologically important enzyme 
involved in retinol esterification i liver [11-13], small 
intestine [9], testis [15,16], and the eye [10,14]. 
Although it is known that the majority of the body's 
retinoid reserves are stored as retinyl ester in hepatic 
fat-storing cells [3-6], nothing is known about the 
cellular distribution of LRAT in the liver. We set out to 
ask if LRAT activity is present solely in the fat-storing 
cells of the liver or, alternatively, if it is also present 
within other cell types of the liver. It is well documented 
that hepatic parenchymal cells contain low levels of 
retinyl esters [3,4] and hence, it might be postulated to 
possess LRAT. However, these cells receive dietary 
retinoid in the form of retinyl ester in chylomicron rem- 
nants and although it is well established that the bulk of 
this retinyl ester is hydrolyzed before it is transported to
the fat-storing cells for storage as retinyl ester [19], 
some of this chylomicron remnant retinyl ester may re- 
main unhydrolyzed in the parenchymal cells. Thus, it is 
unclear if the retinyl ester present in parenchymal cells 
is of dietary origin or if it results from the action of 
LRAT activity within parenchymal cells. Our findings, 
presented in Table I, clearly demonstrate hat the fat- 
storing cell microsomes are especially enriched in 
LRAT activity, and in addition, the parenchymal cells 
also contain a substantial level of LRAT activity. This 
indicates that parenchymal cells, along with the fat- 
storing cells, possess the enzymatic ability to esterify 
retinol and suggests that at least some of the retinyl 
ester present in these ceils arises from esterification of
retinol within these cells. 
Interestingly, LRAT activity was not enriched in the 
isolated fat-storing cell lipid droplet preparations. 
These lipid droplets have been shown to be the site of 
retinyl ester storage in fat-storing cells [8, 20-22]. The 
lipid droplets also have associated with them substantial 
levels of REH [21], which is thought to be necessary for 
the hydrolysis of retinyl esters to retinol during the 
mobilization of retinol from the liver. The relative 
absence of LRAT activity in the lipid droplet fraction 
(as compared to the fat-storing cell microsomes) ug- 
gests that retinyl ester is not synthesized directly at its 
site of storage in the lipid droplets but rather, is made 
at some cellular site which is not directly associated with 
the lipid droplets. 
The Kupffer + endothelial cell microsomes also were 
found to contain some LRAT activity. Although the 
Kupffer + endothelial cell fractions did contain some 
contamination with fat-storing cells, the level of LRAT 
activity in the fraction can not be fully accounted for by 
the fat-storing cell contamination. The level of fat- 
storing cell contamination, as determined by light 
microscopy, for each of the 3 Kupffer + endothelial 
cell fractions employed in this study was always less 
than 15o70 of the total cells present in the preparation. 
Thus, it would seem likely that either the hepatic Kupf- 
fer or endothelial cells (or perhaps both) possess ome 
LRAT activity. 
Our study also raises an interesting technical question 
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which should be considered in future studies of hepatic 
LRAT activity. While carrying out our characteriza- 
tions of the LRAT assay described by Ong et al. [12], 
we observed that retinol-CRBP concentrations a  large 
as 20 #M were only beginning to be rate saturating for 
retinyl ester formation. Ong et al. [12] standardly used 
5 /~M retinol-CRBP for their assays and these in- 
vestigators provided no information indicating if they 
observed full substrate saturation at this concentration. 
Similarly, Yost et al. [13], employed 5 ~M retinol-CRBP 
in their standard assay, but these authors also failed to 
indicate whether this substrate concentration was rate 
saturating. Our observations indicate that the measured 
rate of the LRAT reaction is not independent of 
substrate concentration at concentrations of 
retinol-CRBP below 20 #M (see Fig. 1). Thus, if 5 #M 
retinol-CRBP is standardly used as an assay substrate 
concentration, extreme care must be taken in making 
the measurement of this concentration, in order to 
eliminate the possibility that different reaction rates 
might arise from small differences in substrate concen- 
trations. The use of more nearly saturating concentra- 
tions of retinol-CRBP (>__ 20 #M) however, presents a
practical dilemma regarding the amount of purified 
retinol-CRBP (which is very time consuming and dif- 
ficult to purify) to be used in each assay. For our 
studies, we have chosen to use 10 #M retinol-CRBP as 
our standard substrate concentration. We feel that this 
concentration represents a good compromise between 
wanting to measure assay rates which are independent 
of substrate concentration and the need to conserve 
precious retinol-CRBP. For future more sophisticated 
studies of hepatic LRAT activity, we suggest hat 
careful consideration begiven to the choice of the assay 
retinol-CRBP concentration. Such consideration will 
do much to render appropriate comparisons ofdata ob- 
tained by different laboratories investigating hepatic 
retinoid storage. 
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